vs
AVINO SILVER & GOLD MINES LTD（ASM）与Gossamer Bio, Inc.（GOSS）财务数据对比。点击上方公司名可切换其他公司
AVINO SILVER & GOLD MINES LTD的季度营收约是Gossamer Bio, Inc.的1.5倍（$21.0M vs $13.8M），AVINO SILVER & GOLD MINES LTD净利率更高（36.6% vs -342.3%，领先378.9%），Gossamer Bio, Inc.同比增速更快（47.1% vs 44.0%）
阿维诺金银矿业有限公司是一家加拿大矿业企业，主要从事银、金、铜等贵金属及基本金属的勘探、开发与生产，核心运营资产为位于墨西哥杜兰戈州的旗舰阿维诺矿区，产品供应全球大宗商品市场。
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
ASM vs GOSS — 直观对比
营收规模更大
ASM
是对方的1.5倍
$13.8M
营收增速更快
GOSS
高出3.2%
44.0%
净利率更高
ASM
高出378.9%
-342.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.0M | $13.8M |
| 净利润 | $7.7M | $-47.2M |
| 毛利率 | 47.1% | — |
| 营业利润率 | — | -333.6% |
| 净利率 | 36.6% | -342.3% |
| 营收同比 | 44.0% | 47.1% |
| 净利润同比 | 558.9% | -43.0% |
| 每股收益（稀释后） | $0.05 | $-0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMGOSS
| Q4 25 | — | $13.8M | ||
| Q3 25 | $21.0M | $13.3M | ||
| Q2 25 | $21.8M | — | ||
| Q1 25 | $18.8M | — | ||
| Q3 24 | $14.6M | — | ||
| Q2 24 | $14.8M | $95.8M | ||
| Q1 24 | $12.4M | $0 | ||
| Q3 23 | $12.3M | $0 |
净利润ASMGOSS
| Q4 25 | — | $-47.2M | ||
| Q3 25 | $7.7M | $-48.2M | ||
| Q2 25 | $2.9M | — | ||
| Q1 25 | $5.6M | — | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $1.2M | $49.2M | ||
| Q1 24 | $599.0K | $-41.9M | ||
| Q3 23 | $-803.0K | $-40.0M |
毛利率ASMGOSS
| Q4 25 | — | — | ||
| Q3 25 | 47.1% | — | ||
| Q2 25 | 46.9% | — | ||
| Q1 25 | 56.1% | — | ||
| Q3 24 | 39.1% | — | ||
| Q2 24 | 31.8% | — | ||
| Q1 24 | 18.9% | — | ||
| Q3 23 | 19.2% | — |
营业利润率ASMGOSS
| Q4 25 | — | -333.6% | ||
| Q3 25 | — | -369.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
净利率ASMGOSS
| Q4 25 | — | -342.3% | ||
| Q3 25 | 36.6% | -362.7% | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 29.8% | — | ||
| Q3 24 | 8.0% | — | ||
| Q2 24 | 8.4% | 51.4% | ||
| Q1 24 | 4.8% | — | ||
| Q3 23 | -6.5% | — |
每股收益（稀释后）ASMGOSS
| Q4 25 | — | $-0.21 | ||
| Q3 25 | $0.05 | $-0.21 | ||
| Q2 25 | $0.02 | — | ||
| Q1 25 | $0.04 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $0.01 | $0.22 | ||
| Q1 24 | $0.00 | $-0.19 | ||
| Q3 23 | $-0.01 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $136.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.1M | $-122.8M |
| 总资产 | $221.9M | $172.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMGOSS
| Q4 25 | — | $136.9M | ||
| Q3 25 | $57.3M | $180.2M | ||
| Q2 25 | $37.3M | — | ||
| Q1 25 | $26.6M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $5.3M | $354.5M | ||
| Q1 24 | $3.5M | $244.4M | ||
| Q3 23 | $1.9M | $328.9M |
股东权益ASMGOSS
| Q4 25 | — | $-122.8M | ||
| Q3 25 | $182.1M | $-82.3M | ||
| Q2 25 | $144.8M | — | ||
| Q1 25 | $132.3M | — | ||
| Q3 24 | $114.5M | — | ||
| Q2 24 | $112.2M | $81.5M | ||
| Q1 24 | $107.8M | $26.7M | ||
| Q3 23 | $102.7M | $104.6M |
总资产ASMGOSS
| Q4 25 | — | $172.2M | ||
| Q3 25 | $221.9M | $208.8M | ||
| Q2 25 | $174.7M | — | ||
| Q1 25 | $157.7M | — | ||
| Q3 24 | $135.4M | — | ||
| Q2 24 | $133.7M | $373.4M | ||
| Q1 24 | $128.6M | $259.4M | ||
| Q3 23 | $123.5M | $347.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.3M | $-48.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.08× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMGOSS
| Q4 25 | — | $-48.3M | ||
| Q3 25 | $8.3M | $-36.2M | ||
| Q2 25 | $8.3M | — | ||
| Q1 25 | $758.0K | — | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $1.1M | $116.3M | ||
| Q1 24 | $2.3M | $-52.3M | ||
| Q3 23 | $-83.0K | $-34.5M |
资本支出强度ASMGOSS
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
现金转化率ASMGOSS
| Q4 25 | — | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 2.92× | — | ||
| Q1 25 | 0.13× | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | 0.87× | 2.36× | ||
| Q1 24 | 3.92× | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
